A comparison of anabolic treatment regimes was made in 761 autumn-born Friesian steers on 14 farms. Prior to turn-out for grazing at 6 months of age and approximately 180 kg live weight, steers were weighed and divided into three equal-weight groups. Group 1 received silastic implants containing 45 mg oestradiol-17β. Group 2 received 36 mg zeranol and group 3 were untreated controls. All steers were weighed at intervals of approximately 3 months (i.e. mid summer, yarding at autumn, mid winter and pre-slaughter) and group 2 steers received a further 36 mg zeranol at the second, third and fourth weighing. At the third weighing half the cattle in each of the treatment groups 1 and 2 received 300 mg trenbolone acetate. Also at the third weighing, group 3 (controls) were subdivided into three equal-weight groups, the first of which received 45 mg oestradiol-17β and 300 mg trenbolone acetate and the second 36 mg zeranol and 300 mg trenbolone acetate. The third subgroup remained as untreated controls.

From 10 farms a 25% sample close to group mean weight at mid winter were slaughtered on the same day and subjectively assessed for subcutaneous fat score and conformation on 15-point scales. The left thin flank was separated into tissues. Samples of lean fat, liver and kidney were analysed for zeranol residues. All implant treatments resulted in higher live-weight gain, heavier slaughter weights and earlier slaughter. Trenbolone increased daily gain only during the first 3 months after treatment. Implanted carcasses were heavier both in the fore- and hindquarter but trenbolone also produced heavier forequarters. Carcasses from treated steers had more subcutaneous fat, less perinephric and retroperitoneal fat and less intermuscular fat in the thin-flank joint. Zeranol residues in implanted steers were not significantly higher than controls except in the kidney, but even these were significantly below accepted tolerance levels.